Related Experiment Video
Updated: Apr 1, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
The Crusade against Mutant p53: Does the COMPASS Point to the Holy Grail?
Christopher G Abraham1, Joaquín M Espinosa1
1Linda Crnic Institute for Down Syndrome, University of Colorado Denver School Of Medicine, Aurora, CO 80045, USA; Department of Pharmacology, University of Colorado Denver School Of Medicine, Aurora, CO 80045, USA.
Abstract:
Mutations in the TP53 gene not only inactivate its tumor suppressor function but also confer this transcription factor with gain-of-function oncogenic properties. A recent paper by Zhu and colleagues reveals a novel molecular pathway driven by mutant p53 and the COMPASS chromatin-modifying complex that is amenable to pharmacological inhibition.
Insights
Mutant TP53 protein gains cancer-driving abilities. Researchers discovered a new pathway involving mutant p53 and the COMPASS complex that can be targeted by drugs.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mutations in the TP53 gene are common in cancer.
- Mutant p53 can acquire new oncogenic functions beyond inactivating tumor suppression.
Purpose of the Study:
- To identify novel molecular pathways driven by mutant p53.
- To explore potential therapeutic targets for cancers with TP53 mutations.
Main Methods:
- Investigated the interaction between mutant p53 and chromatin-modifying complexes.
- Utilized molecular biology techniques to elucidate the pathway.
Main Results:
- Identified a novel pathway driven by mutant p53 and the COMPASS complex.
- Demonstrated that this pathway contributes to oncogenesis.
Conclusions:
- Mutant p53 cooperates with the COMPASS complex to promote cancer.
- This pathway represents a potential target for pharmacological intervention in TP53-mutated cancers.
Related Concept Videos
Abnormal Proliferation
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Anaphase Promoting Complex
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...

